13F Holdings
中文EN

ICU SeaStar Medical Holding Corp

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1831868 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY145.7%
TTM net income YoY-7.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin92.6%
Operating margin-692.4%
Net margin-678.2%
FCF margin—
EBITDA margin—

Returns

ROE-246.1%
ROA-140.9%
ROIC (approx.)—
Asset turnover0.21x

Leverage & solvency

Liabilities / assets91.2%
Debt / equity0.00x
Current ratio1.03x
Interest coverage-516.93x

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-14.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.23M$135,000$0——
Cost of revenue$53,000$0$0——
Gross profit$1.18M$135,000$0——
R&D expense$7.52M$9.11M$5.97M$2.50M$2.77M
SG&A expense$5.84M$8.87M$8.24M$6.92M$1.68M
Operating income-$12.18M-$17.84M-$14.21M-$11.61M-$4.45M
Interest expense$31,000$244,000$1.08M$630,000$212,000
Pretax income-$12.15M-$24.83M-$26.23M-$12.19M-$4.60M
Income tax$3,000$3,000$0$1,000-$1,000
Net income-$12.15M-$24.83M-$26.23M-$12.19M-$4.60M
EPS (basic)-5.86-66.33-30.26-1.48-0.63
EPS (diluted)—-6.63-30.26-1.48-0.63
Weighted avg. shares (diluted)—3.74M866,8138.21M7.24M
Balance sheet
Cash & equivalents$11.98M$1.82M$176,000$47,000$510,000
Receivables$237,000$112,000$0——
Inventory$66,000$0———
Current assets$13.58M$3.77M$2.31M$1.52M$601,000
Total assets$14.16M$4.66M$3.51M$3.04M$603,000
Current liabilities$3.74M$6.84M$13.05M$16.15M$3.12M
Short-term debt—$574,000$565,000$1.18M—
Long-term debt——$4.14M$7.65M—
Total debt——$4.71M$8.83M—
Total liabilities$3.74M$6.84M$17.38M$23.80M$3.42M
Shareholders' equity$10.42M-$2.18M-$13.87M-$20.76M-$2.82M
Net debt——$4.53M$8.78M—
Shares outstanding3.84M650,6392.02M12.70M—
Cash flow statement
Operating cash flow-$13.60M-$16.01M-$10.29M-$7.79M-$5.11M
Investing cash flow————-$105.57M
Financing cash flow$23.76M$17.65M$10.41M$7.33M$2.82M
Stock-based compensation$624,000$887,000$1.93M$1.31M$14,000

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.